The 13th China IVD Industry Development Conference, the 11th China Experimental Medicine Conference and the 2nd China AI and Digital Twin Technology Medicine Conference will take place from 20-22 March 2026 at Xiamen International Expo Center.
Over 300 speakers will share their experience, opinions and new cutting-edge results in person during this event. The conferences are undoubtedly beneficial to every player and researcher in the IVD and laboratory medicine.
The China lVD Industry Development Conference is organised by the China Association of In-Vitro Diagnostics (CAIVD). The conference focuses on industrial development, latest trends, capital operations and business management. Several elites and entrepreneurs in the IVD industry will discuss in person artificial intelligence, business models, and international opportunities among other topics.
Industry development
21-22 March, 2026
Xiamen International Expo Center
The China Experimental Medicine Conference is organised by the China Professional Community of Experimental Medicine (CPCEM). Academicians, experts and scholars will report on the latest developments in experimental medicine, biomedical engineering, molecular diagnosis, pathology, mass spectrometry, blood transfusion, clinical and laboratory, creative medical management and other relevant topics.
Laboratory medicine
21-22 March, 2026
Xiamen International Expo Center
The IVD "blue book" gives detailed, updated and complete information about the IVD Industry In ChIna. It consists of eight parts, IncludIng an overview on the lVD Industry in China, academIc, technology and product development in the field of IVD. An essential reference book for IVD practitioners all over the world.
Copyright © 2026 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.